nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SLC6A5—brainstem—peripheral nervous system neoplasm	0.0167	0.0632	CbGeAlD
Glycine—GARS—nerve—peripheral nervous system neoplasm	0.0144	0.0545	CbGeAlD
Glycine—GRIN2C—nerve—peripheral nervous system neoplasm	0.0142	0.0536	CbGeAlD
Glycine—Diuresis—Cisplatin—peripheral nervous system neoplasm	0.0109	0.0271	CcSEcCtD
Glycine—GRIN2A—nerve—peripheral nervous system neoplasm	0.00981	0.0371	CbGeAlD
Glycine—GRIN2A—ganglion—peripheral nervous system neoplasm	0.00968	0.0366	CbGeAlD
Glycine—GLDC—trigeminal ganglion—peripheral nervous system neoplasm	0.00968	0.0366	CbGeAlD
Glycine—GNMT—parotid gland—peripheral nervous system neoplasm	0.00963	0.0364	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—peripheral nervous system neoplasm	0.0095	0.592	CbGdCrCtD
Glycine—Acidosis—Tretinoin—peripheral nervous system neoplasm	0.00946	0.0235	CcSEcCtD
Glycine—Acidosis—Isotretinoin—peripheral nervous system neoplasm	0.00946	0.0235	CcSEcCtD
Glycine—PIPOX—trigeminal ganglion—peripheral nervous system neoplasm	0.00904	0.0341	CbGeAlD
Glycine—GLRA2—brainstem—peripheral nervous system neoplasm	0.00879	0.0332	CbGeAlD
Glycine—GSS—ganglion—peripheral nervous system neoplasm	0.00847	0.032	CbGeAlD
Glycine—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.00843	0.0209	CcSEcCtD
Glycine—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.00843	0.0209	CcSEcCtD
Glycine—Encephalopathy—Isotretinoin—peripheral nervous system neoplasm	0.00816	0.0203	CcSEcCtD
Glycine—Encephalopathy—Tretinoin—peripheral nervous system neoplasm	0.00816	0.0203	CcSEcCtD
Glycine—GCAT—brainstem—peripheral nervous system neoplasm	0.00776	0.0293	CbGeAlD
Glycine—ALAS1—trigeminal ganglion—peripheral nervous system neoplasm	0.00768	0.029	CbGeAlD
Glycine—Lung disorder—Topotecan—peripheral nervous system neoplasm	0.00746	0.0185	CcSEcCtD
Glycine—Lung disorder—Isotretinoin—peripheral nervous system neoplasm	0.0074	0.0184	CcSEcCtD
Glycine—Lung disorder—Tretinoin—peripheral nervous system neoplasm	0.0074	0.0184	CcSEcCtD
Glycine—ALAS1—parotid gland—peripheral nervous system neoplasm	0.00725	0.0274	CbGeAlD
Glycine—Acidosis—Alitretinoin—peripheral nervous system neoplasm	0.00717	0.0178	CcSEcCtD
Glycine—GARS—trigeminal ganglion—peripheral nervous system neoplasm	0.007	0.0264	CbGeAlD
Glycine—GARS—parotid gland—peripheral nervous system neoplasm	0.0066	0.0249	CbGeAlD
Glycine—SHMT1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00654	0.408	CbGdCrCtD
Glycine—SLC32A1—cerebellum—peripheral nervous system neoplasm	0.00647	0.0245	CbGeAlD
Glycine—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.00639	0.0159	CcSEcCtD
Glycine—GARS—brainstem—peripheral nervous system neoplasm	0.00619	0.0234	CbGeAlD
Glycine—Encephalopathy—Alitretinoin—peripheral nervous system neoplasm	0.00619	0.0154	CcSEcCtD
Glycine—GRIN2C—brainstem—peripheral nervous system neoplasm	0.00609	0.023	CbGeAlD
Glycine—Cardiovascular disorder—Isotretinoin—peripheral nervous system neoplasm	0.00596	0.0148	CcSEcCtD
Glycine—Cardiovascular disorder—Tretinoin—peripheral nervous system neoplasm	0.00596	0.0148	CcSEcCtD
Glycine—GATM—brainstem—peripheral nervous system neoplasm	0.00588	0.0222	CbGeAlD
Glycine—SHMT2—parotid gland—peripheral nervous system neoplasm	0.00574	0.0217	CbGeAlD
Glycine—Lung disorder—Alitretinoin—peripheral nervous system neoplasm	0.00561	0.0139	CcSEcCtD
Glycine—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.00544	0.0135	CcSEcCtD
Glycine—GLRB—parotid gland—peripheral nervous system neoplasm	0.00538	0.0203	CbGeAlD
Glycine—AGXT—cerebellum—peripheral nervous system neoplasm	0.00532	0.0201	CbGeAlD
Glycine—SHMT1—parotid gland—peripheral nervous system neoplasm	0.00523	0.0198	CbGeAlD
Glycine—GCSH—cerebellum—peripheral nervous system neoplasm	0.0051	0.0193	CbGeAlD
Glycine—Coma—Isotretinoin—peripheral nervous system neoplasm	0.00479	0.0119	CcSEcCtD
Glycine—Coma—Tretinoin—peripheral nervous system neoplasm	0.00479	0.0119	CcSEcCtD
Glycine—Lightheadedness—Isotretinoin—peripheral nervous system neoplasm	0.00469	0.0116	CcSEcCtD
Glycine—Lightheadedness—Tretinoin—peripheral nervous system neoplasm	0.00469	0.0116	CcSEcCtD
Glycine—Cardiovascular disorder—Alitretinoin—peripheral nervous system neoplasm	0.00452	0.0112	CcSEcCtD
Glycine—GLRA2—cerebellum—peripheral nervous system neoplasm	0.00433	0.0164	CbGeAlD
Glycine—GLDC—cerebellum—peripheral nervous system neoplasm	0.00422	0.016	CbGeAlD
Glycine—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00421	0.0159	CbGeAlD
Glycine—SLC36A1—brainstem—peripheral nervous system neoplasm	0.00418	0.0158	CbGeAlD
Glycine—GSS—trigeminal ganglion—peripheral nervous system neoplasm	0.00416	0.0157	CbGeAlD
Glycine—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.00401	0.00996	CcSEcCtD
Glycine—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.00401	0.00996	CcSEcCtD
Glycine—PIPOX—cerebellum—peripheral nervous system neoplasm	0.00394	0.0149	CbGeAlD
Glycine—GSS—parotid gland—peripheral nervous system neoplasm	0.00393	0.0148	CbGeAlD
Glycine—GCAT—cerebellum—peripheral nervous system neoplasm	0.00382	0.0145	CbGeAlD
Glycine—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.00377	0.00936	CcSEcCtD
Glycine—GSS—brainstem—peripheral nervous system neoplasm	0.00368	0.0139	CbGeAlD
Glycine—Coma—Alitretinoin—peripheral nervous system neoplasm	0.00363	0.00901	CcSEcCtD
Glycine—Lightheadedness—Alitretinoin—peripheral nervous system neoplasm	0.00355	0.00882	CcSEcCtD
Glycine—Dehydration—Isotretinoin—peripheral nervous system neoplasm	0.00354	0.00878	CcSEcCtD
Glycine—Dehydration—Tretinoin—peripheral nervous system neoplasm	0.00354	0.00878	CcSEcCtD
Glycine—Cardiovascular disorder—Etoposide—peripheral nervous system neoplasm	0.00353	0.00876	CcSEcCtD
Glycine—Coma—Vincristine—peripheral nervous system neoplasm	0.0035	0.00868	CcSEcCtD
Glycine—ALAS1—cerebellum—peripheral nervous system neoplasm	0.00335	0.0127	CbGeAlD
Glycine—Polyuria—Vincristine—peripheral nervous system neoplasm	0.00316	0.00785	CcSEcCtD
Glycine—GARS—cerebellum—peripheral nervous system neoplasm	0.00305	0.0115	CbGeAlD
Glycine—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00755	CcSEcCtD
Glycine—GRIN2C—cerebellum—peripheral nervous system neoplasm	0.003	0.0114	CbGeAlD
Glycine—GATM—cerebellum—peripheral nervous system neoplasm	0.0029	0.011	CbGeAlD
Glycine—SLC16A10—parotid gland—peripheral nervous system neoplasm	0.00288	0.0109	CbGeAlD
Glycine—Polyuria—Cisplatin—peripheral nervous system neoplasm	0.0028	0.00694	CcSEcCtD
Glycine—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00279	0.00692	CcSEcCtD
Glycine—Dehydration—Alitretinoin—peripheral nervous system neoplasm	0.00268	0.00665	CcSEcCtD
Glycine—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.00266	0.0066	CcSEcCtD
Glycine—SHMT2—cerebellum—peripheral nervous system neoplasm	0.00266	0.01	CbGeAlD
Glycine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.00264	0.00656	CcSEcCtD
Glycine—Dehydration—Vincristine—peripheral nervous system neoplasm	0.00258	0.00641	CcSEcCtD
Glycine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.00254	0.00629	CcSEcCtD
Glycine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.00254	0.00629	CcSEcCtD
Glycine—GLRB—cerebellum—peripheral nervous system neoplasm	0.00249	0.00941	CbGeAlD
Glycine—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00612	CcSEcCtD
Glycine—Lung disorder—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00609	CcSEcCtD
Glycine—SHMT1—cerebellum—peripheral nervous system neoplasm	0.00242	0.00914	CbGeAlD
Glycine—Chills—Topotecan—peripheral nervous system neoplasm	0.00238	0.00591	CcSEcCtD
Glycine—Chills—Isotretinoin—peripheral nervous system neoplasm	0.00236	0.00586	CcSEcCtD
Glycine—Chills—Tretinoin—peripheral nervous system neoplasm	0.00236	0.00586	CcSEcCtD
Glycine—Dehydration—Cisplatin—peripheral nervous system neoplasm	0.00228	0.00567	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00564	CcSEcCtD
Glycine—Back pain—Topotecan—peripheral nervous system neoplasm	0.00223	0.00554	CcSEcCtD
Glycine—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00222	0.0055	CcSEcCtD
Glycine—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00222	0.0055	CcSEcCtD
Glycine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00536	CcSEcCtD
Glycine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00536	CcSEcCtD
Glycine—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.00208	0.00784	CbGeAlD
Glycine—SLC36A1—cerebellum—peripheral nervous system neoplasm	0.00206	0.00779	CbGeAlD
Glycine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00198	0.00493	CcSEcCtD
Glycine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.00493	CcSEcCtD
Glycine—Cardiovascular disorder—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00491	CcSEcCtD
Glycine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00196	0.00486	CcSEcCtD
Glycine—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00193	0.00479	CcSEcCtD
Glycine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00477	CcSEcCtD
Glycine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00187	0.00464	CcSEcCtD
Glycine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00187	0.00464	CcSEcCtD
Glycine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00185	0.00458	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00454	CcSEcCtD
Glycine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00453	CcSEcCtD
Glycine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00453	CcSEcCtD
Glycine—GSS—cerebellum—peripheral nervous system neoplasm	0.00182	0.00686	CbGeAlD
Glycine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.0018	0.00447	CcSEcCtD
Glycine—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00444	CcSEcCtD
Glycine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00175	0.00434	CcSEcCtD
Glycine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.00434	CcSEcCtD
Glycine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00172	0.00428	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00419	CcSEcCtD
Glycine—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00417	CcSEcCtD
Glycine—GLYATL2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00167	0.00529	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00167	0.00529	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00167	0.00529	CbGpPWpGaD
Glycine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00406	CcSEcCtD
Glycine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00406	CcSEcCtD
Glycine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00162	0.00402	CcSEcCtD
Glycine—Pain—Topotecan—peripheral nervous system neoplasm	0.00161	0.004	CcSEcCtD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.0016	0.00506	CbGpPWpGaD
Glycine—Pain—Tretinoin—peripheral nervous system neoplasm	0.0016	0.00397	CcSEcCtD
Glycine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.00397	CcSEcCtD
Glycine—BAAT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0016	0.00505	CbGpPWpGaD
Glycine—Coma—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00394	CcSEcCtD
Glycine—SLC32A1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00159	0.00501	CbGpPWpGaD
Glycine—Pain—Melphalan—peripheral nervous system neoplasm	0.00158	0.00392	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00156	0.00388	CcSEcCtD
Glycine—AGXT2—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00155	0.0049	CbGpPWpGaD
Glycine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00155	0.00489	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00154	0.00486	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00154	0.00486	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00154	0.00486	CbGpPWpGaD
Glycine—GARS—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00153	0.00485	CbGpPWpGaD
Glycine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00153	0.00379	CcSEcCtD
Glycine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00373	CcSEcCtD
Glycine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.0015	0.00373	CcSEcCtD
Glycine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.0015	0.00372	CcSEcCtD
Glycine—ALAS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00149	0.00472	CbGpPWpGaD
Glycine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00369	CcSEcCtD
Glycine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00369	CcSEcCtD
Glycine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00365	CcSEcCtD
Glycine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00147	0.00364	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00146	0.00462	CbGpPWpGaD
Glycine—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00362	CcSEcCtD
Glycine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00145	0.0036	CcSEcCtD
Glycine—AGXT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00142	0.0045	CbGpPWpGaD
Glycine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00352	CcSEcCtD
Glycine—Chills—Etoposide—peripheral nervous system neoplasm	0.0014	0.00347	CcSEcCtD
Glycine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00346	CcSEcCtD
Glycine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00139	0.00345	CcSEcCtD
Glycine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00343	CcSEcCtD
Glycine—ALAS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00138	0.00436	CbGpPWpGaD
Glycine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00342	CcSEcCtD
Glycine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00342	CcSEcCtD
Glycine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00137	0.00339	CcSEcCtD
Glycine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00136	0.00337	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00335	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00133	0.00421	CbGpPWpGaD
Glycine—SLC16A10—cerebellum—peripheral nervous system neoplasm	0.00133	0.00503	CbGeAlD
Glycine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00329	CcSEcCtD
Glycine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00131	0.00325	CcSEcCtD
Glycine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00324	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.00129	0.00408	CbGpPWpGaD
Glycine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00129	0.0032	CcSEcCtD
Glycine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00318	CcSEcCtD
Glycine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00318	CcSEcCtD
Glycine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00318	CcSEcCtD
Glycine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00128	0.00317	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00127	0.00403	CbGpPWpGaD
Glycine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00314	CcSEcCtD
Glycine—SHMT1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00126	0.00399	CbGpPWpGaD
Glycine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00126	0.00313	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00125	0.00396	CbGpPWpGaD
Glycine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00125	0.00309	CcSEcCtD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.00124	0.00393	CbGpPWpGaD
Glycine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00307	CcSEcCtD
Glycine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00307	CcSEcCtD
Glycine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00122	0.00302	CcSEcCtD
Glycine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00301	CcSEcCtD
Glycine—AGXT2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00121	0.00383	CbGpPWpGaD
Glycine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00121	0.003	CcSEcCtD
Glycine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0012	0.00297	CcSEcCtD
Glycine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00295	CcSEcCtD
Glycine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00295	CcSEcCtD
Glycine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.00118	0.00373	CbGpPWpGaD
Glycine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00292	CcSEcCtD
Glycine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00117	0.00291	CcSEcCtD
Glycine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00117	0.00291	CcSEcCtD
Glycine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00291	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00291	CcSEcCtD
Glycine—Pain—Vincristine—peripheral nervous system neoplasm	0.00117	0.0029	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00116	0.00366	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00113	0.00357	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00113	0.00357	CbGpPWpGaD
Glycine—GLYAT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00113	0.00357	CbGpPWpGaD
Glycine—GATM—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00113	0.00357	CbGpPWpGaD
Glycine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00113	0.0028	CcSEcCtD
Glycine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00113	0.00279	CcSEcCtD
Glycine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00279	CcSEcCtD
Glycine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00112	0.00278	CcSEcCtD
Glycine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00276	CcSEcCtD
Glycine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00276	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00111	0.00351	CbGpPWpGaD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.0011	0.00349	CbGpPWpGaD
Glycine—Nausea—Melphalan—peripheral nervous system neoplasm	0.0011	0.00272	CcSEcCtD
Glycine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00269	CcSEcCtD
Glycine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00108	0.00268	CcSEcCtD
Glycine—ALAS2—Metabolism—GNS—peripheral nervous system neoplasm	0.00108	0.00341	CbGpPWpGaD
Glycine—BAAT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00108	0.00341	CbGpPWpGaD
Glycine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00264	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00105	0.0026	CcSEcCtD
Glycine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00259	CcSEcCtD
Glycine—ALAS2—Metabolism—NME1—peripheral nervous system neoplasm	0.00103	0.00327	CbGpPWpGaD
Glycine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00103	0.00257	CcSEcCtD
Glycine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00256	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00101	0.0032	CbGpPWpGaD
Glycine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00101	0.0025	CcSEcCtD
Glycine—GRIN2C—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.001	0.00317	CbGpPWpGaD
Glycine—ALAS2—Metabolism—COX2—peripheral nervous system neoplasm	0.000996	0.00315	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00099	0.00313	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000987	0.00312	CbGpPWpGaD
Glycine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000982	0.00244	CcSEcCtD
Glycine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000971	0.00241	CcSEcCtD
Glycine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000969	0.00241	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000966	0.00305	CbGpPWpGaD
Glycine—GSS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000962	0.00304	CbGpPWpGaD
Glycine—AGXT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000962	0.00304	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000957	0.00302	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000957	0.00302	CbGpPWpGaD
Glycine—Pain—Etoposide—peripheral nervous system neoplasm	0.000946	0.00235	CcSEcCtD
Glycine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000937	0.00233	CcSEcCtD
Glycine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000934	0.00232	CcSEcCtD
Glycine—ALAS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000931	0.00294	CbGpPWpGaD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000919	0.0029	CbGpPWpGaD
Glycine—GRIN2C—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000908	0.00287	CbGpPWpGaD
Glycine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000908	0.00225	CcSEcCtD
Glycine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000903	0.00224	CcSEcCtD
Glycine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000901	0.00224	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000897	0.00283	CbGpPWpGaD
Glycine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000889	0.00221	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000886	0.0028	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000883	0.00279	CbGpPWpGaD
Glycine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000878	0.00218	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000877	0.00277	CbGpPWpGaD
Glycine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000875	0.00217	CcSEcCtD
Glycine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000868	0.00215	CcSEcCtD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.000842	0.00266	CbGpPWpGaD
Glycine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000841	0.00209	CcSEcCtD
Glycine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000841	0.00209	CcSEcCtD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000836	0.00264	CbGpPWpGaD
Glycine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000826	0.00205	CcSEcCtD
Glycine—GLYAT—Metabolism—GNS—peripheral nervous system neoplasm	0.000818	0.00258	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GNS—peripheral nervous system neoplasm	0.000818	0.00258	CbGpPWpGaD
Glycine—GATM—Metabolism—GNS—peripheral nervous system neoplasm	0.000818	0.00258	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GNS—peripheral nervous system neoplasm	0.000818	0.00258	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000818	0.00258	CbGpPWpGaD
Glycine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000815	0.00202	CcSEcCtD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000813	0.00257	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000813	0.00257	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000813	0.00257	CbGpPWpGaD
Glycine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000811	0.00201	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00081	0.00256	CbGpPWpGaD
Glycine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.00201	CcSEcCtD
Glycine—GRIN2C—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000807	0.00255	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000803	0.00254	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NME1—peripheral nervous system neoplasm	0.000784	0.00248	CbGpPWpGaD
Glycine—GATM—Metabolism—NME1—peripheral nervous system neoplasm	0.000784	0.00248	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NME1—peripheral nervous system neoplasm	0.000784	0.00248	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NME1—peripheral nervous system neoplasm	0.000784	0.00248	CbGpPWpGaD
Glycine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000783	0.00194	CcSEcCtD
Glycine—BAAT—Metabolism—GNS—peripheral nervous system neoplasm	0.00078	0.00246	CbGpPWpGaD
Glycine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000778	0.00193	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000774	0.00245	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00077	0.00243	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00077	0.00243	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000769	0.00243	CbGpPWpGaD
Glycine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000767	0.00191	CcSEcCtD
Glycine—GRIN2A—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000766	0.00242	CbGpPWpGaD
Glycine—GRIN2A—Reelin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000765	0.00242	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000762	0.00241	CbGpPWpGaD
Glycine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000757	0.00188	CcSEcCtD
Glycine—SLC6A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000755	0.00239	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000755	0.00239	CbGpPWpGaD
Glycine—GLYAT—Metabolism—COX2—peripheral nervous system neoplasm	0.000755	0.00238	CbGpPWpGaD
Glycine—GATM—Metabolism—COX2—peripheral nervous system neoplasm	0.000755	0.00238	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—COX2—peripheral nervous system neoplasm	0.000755	0.00238	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—COX2—peripheral nervous system neoplasm	0.000755	0.00238	CbGpPWpGaD
Glycine—BAAT—Metabolism—NME1—peripheral nervous system neoplasm	0.000748	0.00236	CbGpPWpGaD
Glycine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000735	0.00182	CcSEcCtD
Glycine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000731	0.00182	CcSEcCtD
Glycine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.0018	CcSEcCtD
Glycine—BAAT—Metabolism—COX2—peripheral nervous system neoplasm	0.00072	0.00227	CbGpPWpGaD
Glycine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000717	0.00178	CcSEcCtD
Glycine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000716	0.00178	CcSEcCtD
Glycine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000703	0.00175	CcSEcCtD
Glycine—AGXT—Metabolism—GNS—peripheral nervous system neoplasm	0.000695	0.0022	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000693	0.00219	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000684	0.00216	CbGpPWpGaD
Glycine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000682	0.00169	CcSEcCtD
Glycine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00068	0.00169	CcSEcCtD
Glycine—ALAS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000673	0.00213	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000667	0.00211	CbGpPWpGaD
Glycine—AGXT—Metabolism—NME1—peripheral nervous system neoplasm	0.000667	0.00211	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000663	0.0021	CbGpPWpGaD
Glycine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.00164	CcSEcCtD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.00066	0.00208	CbGpPWpGaD
Glycine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000658	0.00163	CcSEcCtD
Glycine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000657	0.00163	CcSEcCtD
Glycine—GPR18—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000656	0.00207	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000654	0.00207	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000654	0.00207	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000654	0.00207	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000654	0.00207	CbGpPWpGaD
Glycine—GSS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00065	0.00205	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NME1—peripheral nervous system neoplasm	0.000646	0.00204	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000642	0.00203	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000642	0.00203	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000642	0.00203	CbGpPWpGaD
Glycine—AGXT—Metabolism—COX2—peripheral nervous system neoplasm	0.000642	0.00203	CbGpPWpGaD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000639	0.00202	CbGpPWpGaD
Glycine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.00157	CcSEcCtD
Glycine—ALAS1—Metabolism—COX2—peripheral nervous system neoplasm	0.000621	0.00196	CbGpPWpGaD
Glycine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00154	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000616	0.00195	CbGpPWpGaD
Glycine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000609	0.00151	CcSEcCtD
Glycine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000605	0.0015	CcSEcCtD
Glycine—AGXT2—Metabolism—GNS—peripheral nervous system neoplasm	0.000591	0.00187	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000587	0.00185	CbGpPWpGaD
Glycine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000579	0.00144	CcSEcCtD
Glycine—SHMT1—Disease—GNS—peripheral nervous system neoplasm	0.000575	0.00182	CbGpPWpGaD
Glycine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00142	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000573	0.00181	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NME1—peripheral nervous system neoplasm	0.000567	0.00179	CbGpPWpGaD
Glycine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00139	CcSEcCtD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000559	0.00177	CbGpPWpGaD
Glycine—ALAS2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000552	0.00175	CbGpPWpGaD
Glycine—AGXT2—Metabolism—COX2—peripheral nervous system neoplasm	0.000546	0.00172	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000537	0.0017	CbGpPWpGaD
Glycine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.00133	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000533	0.00169	CbGpPWpGaD
Glycine—Pain—Epirubicin—peripheral nervous system neoplasm	0.00053	0.00132	CcSEcCtD
Glycine—ALAS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000527	0.00166	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000524	0.00166	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000523	0.00165	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00052	0.00164	CbGpPWpGaD
Glycine—ALAS2—Metabolism—TH—peripheral nervous system neoplasm	0.000519	0.00164	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000518	0.00164	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000518	0.00164	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000501	0.00158	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000495	0.00157	CbGpPWpGaD
Glycine—GATM—Metabolism—ENO2—peripheral nervous system neoplasm	0.000495	0.00157	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000495	0.00157	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000495	0.00157	CbGpPWpGaD
Glycine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000492	0.00122	CcSEcCtD
Glycine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00122	CcSEcCtD
Glycine—SLC32A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000486	0.00153	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNS—peripheral nervous system neoplasm	0.000482	0.00152	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000478	0.00151	CbGpPWpGaD
Glycine—BAAT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000473	0.00149	CbGpPWpGaD
Glycine—GSS—Metabolism—GNS—peripheral nervous system neoplasm	0.00047	0.00148	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000467	0.00148	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NME1—peripheral nervous system neoplasm	0.000462	0.00146	CbGpPWpGaD
Glycine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000457	0.00113	CcSEcCtD
Glycine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00113	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000455	0.00144	CbGpPWpGaD
Glycine—GSS—Metabolism—NME1—peripheral nervous system neoplasm	0.00045	0.00142	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COX2—peripheral nervous system neoplasm	0.000445	0.00141	CbGpPWpGaD
Glycine—GSS—Metabolism—COX2—peripheral nervous system neoplasm	0.000433	0.00137	CbGpPWpGaD
Glycine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000424	0.00105	CcSEcCtD
Glycine—ALAS2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000424	0.00134	CbGpPWpGaD
Glycine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.00105	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000422	0.00133	CbGpPWpGaD
Glycine—AGXT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000421	0.00133	CbGpPWpGaD
Glycine—GATM—Metabolism—BCHE—peripheral nervous system neoplasm	0.000419	0.00132	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000419	0.00132	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000419	0.00132	CbGpPWpGaD
Glycine—GLYAT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000419	0.00132	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000416	0.00131	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000414	0.00131	CbGpPWpGaD
Glycine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00102	CcSEcCtD
Glycine—ALAS1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000408	0.00129	CbGpPWpGaD
Glycine—SHMT1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000402	0.00127	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000399	0.00126	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000399	0.00126	CbGpPWpGaD
Glycine—BAAT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000399	0.00126	CbGpPWpGaD
Glycine—GATM—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000399	0.00126	CbGpPWpGaD
Glycine—GLYAT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000399	0.00126	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000395	0.00125	CbGpPWpGaD
Glycine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000978	CcSEcCtD
Glycine—GLYATL2—Metabolism—TH—peripheral nervous system neoplasm	0.000394	0.00124	CbGpPWpGaD
Glycine—GLYAT—Metabolism—TH—peripheral nervous system neoplasm	0.000394	0.00124	CbGpPWpGaD
Glycine—GATM—Metabolism—TH—peripheral nervous system neoplasm	0.000394	0.00124	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TH—peripheral nervous system neoplasm	0.000394	0.00124	CbGpPWpGaD
Glycine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000974	CcSEcCtD
Glycine—BAAT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000381	0.0012	CbGpPWpGaD
Glycine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000942	CcSEcCtD
Glycine—SLC36A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000376	0.00119	CbGpPWpGaD
Glycine—BAAT—Metabolism—TH—peripheral nervous system neoplasm	0.000375	0.00119	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000372	0.00118	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000369	0.00117	CbGpPWpGaD
Glycine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000914	CcSEcCtD
Glycine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000905	CcSEcCtD
Glycine—GPR18—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000359	0.00113	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000358	0.00113	CbGpPWpGaD
Glycine—AGXT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000356	0.00112	CbGpPWpGaD
Glycine—SHMT1—Disease—ENO2—peripheral nervous system neoplasm	0.000349	0.0011	CbGpPWpGaD
Glycine—ALAS1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000345	0.00109	CbGpPWpGaD
Glycine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000846	CcSEcCtD
Glycine—AGXT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00034	0.00107	CbGpPWpGaD
Glycine—AGXT—Metabolism—TH—peripheral nervous system neoplasm	0.000335	0.00106	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000329	0.00104	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TH—peripheral nervous system neoplasm	0.000324	0.00102	CbGpPWpGaD
Glycine—GATM—Metabolism—GNAS—peripheral nervous system neoplasm	0.000321	0.00102	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000321	0.00102	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000321	0.00102	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000321	0.00102	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000316	0.000999	CbGpPWpGaD
Glycine—GATM—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000315	0.000996	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000315	0.000996	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000315	0.000996	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000315	0.000996	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000313	0.00099	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000307	0.000971	CbGpPWpGaD
Glycine—BAAT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000307	0.000969	CbGpPWpGaD
Glycine—AGXT2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000303	0.000956	CbGpPWpGaD
Glycine—BAAT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000301	0.00095	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000293	0.000925	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000292	0.000923	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000289	0.000912	CbGpPWpGaD
Glycine—GSS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000285	0.000899	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TH—peripheral nervous system neoplasm	0.000285	0.000899	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000284	0.000897	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000281	0.000888	CbGpPWpGaD
Glycine—AGXT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000273	0.000863	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000269	0.000849	CbGpPWpGaD
Glycine—AGXT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000268	0.000847	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000265	0.000836	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00026	0.00082	CbGpPWpGaD
Glycine—SHMT1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000247	0.00078	CbGpPWpGaD
Glycine—GSS—Metabolism—BCHE—peripheral nervous system neoplasm	0.00024	0.00076	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000239	0.000755	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000235	0.000744	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000235	0.000744	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000232	0.000734	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TH—peripheral nervous system neoplasm	0.000232	0.000733	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000229	0.000725	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000228	0.000722	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000228	0.00072	CbGpPWpGaD
Glycine—GSS—Metabolism—TH—peripheral nervous system neoplasm	0.000226	0.000714	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000224	0.000708	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—peripheral nervous system neoplasm	0.000212	0.000671	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00019	0.0006	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000189	0.000598	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000187	0.00059	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000186	0.000587	CbGpPWpGaD
Glycine—GSS—Metabolism—GNAS—peripheral nervous system neoplasm	0.000185	0.000583	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000181	0.000572	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00018	0.00057	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.00018	0.000568	CbGpPWpGaD
Glycine—SHMT1—Disease—PTPN11—peripheral nervous system neoplasm	0.000157	0.000497	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000148	0.000466	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—peripheral nervous system neoplasm	0.000147	0.000465	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000139	0.000439	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000138	0.000435	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000135	0.000427	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000134	0.000423	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—peripheral nervous system neoplasm	0.000124	0.000392	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000123	0.000388	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—peripheral nervous system neoplasm	0.000114	0.000362	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000112	0.000355	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000105	0.00033	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—peripheral nervous system neoplasm	9.45e-05	0.000299	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—peripheral nervous system neoplasm	8.8e-05	0.000278	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—peripheral nervous system neoplasm	8.67e-05	0.000274	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—peripheral nervous system neoplasm	8.67e-05	0.000274	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—peripheral nervous system neoplasm	8.67e-05	0.000274	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—peripheral nervous system neoplasm	8.67e-05	0.000274	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.59e-05	0.000271	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—peripheral nervous system neoplasm	8.27e-05	0.000261	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.21e-05	0.00026	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—peripheral nervous system neoplasm	7.37e-05	0.000233	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.25e-05	0.000229	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—peripheral nervous system neoplasm	7.14e-05	0.000226	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—peripheral nervous system neoplasm	6.91e-05	0.000218	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—peripheral nervous system neoplasm	6.27e-05	0.000198	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—peripheral nervous system neoplasm	6.1e-05	0.000193	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—peripheral nervous system neoplasm	5.11e-05	0.000162	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—peripheral nervous system neoplasm	4.98e-05	0.000157	CbGpPWpGaD
